NCT06873724View on ClinicalTrials.gov

SPY003-207 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Healthy

Interventions

DRUG

SPY003-207

Experimental

OTHER

Placebo

Placebo

Trial Locations (1)

H3P 3P1

RECRUITING

Spyre Site 1, Montreal

All Listed Sponsors

collaborator

Altasciences Company Inc.

INDUSTRY

lead

Spyre Therapeutics, Inc.

INDUSTRY